Evidence map›Paper›PMID 24013719›Full record

ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2013

The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects.

Václav Vaněček, Karel Klíma, Aleš Kohout, René Foltán, Ondřej Jiroušek, Jiří Šedý, Jan Štulík, Eva Syková, Pavla Jendelová

Abstract read
In one paragraph

Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Application of Patient-Specific PCL/Case reports in dentistry · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. An overview of de novo bone generation in animal models.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Biofunctionalized Scaffold in Bone Tissue Repair.International journal of molecular sciences · 2018
    Article
  13. Article
  14. PTH Induces Systemically Administered Mesenchymal Stem Cells to Migrate to and Regenerate Spine Injuries.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Václav VaněčekInstitute of Experimental Medicine, Academy of Sciences of the Czech Republic (ASCR), Vídeňská 1083, 142 20, Prague 4, Czech Republic.
Karel Klíma
Aleš Kohout
René Foltán
Ondřej Jiroušek
Jiří Šedý
Jan Štulík
Eva Syková
Pavla Jendelová

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVertebral body defects represent one of the most common orthopedic challenges. In order to advance the transfer of stem cell therapies into orthopedic clinical practice, we performed this study to evaluate the safety and efficacy of a composite bioartificial graft based on a hydroxyapatite bone scaffold (CEM-OSTETIC(®)) combined with human mesenchymal stem cells (MSCs) in a rat model of vertebral body defects.

methodsUnder general isoflurane anesthesia, a defect in the body of the L2 vertebra was prepared and left to heal spontaneously (group 1), implanted with scaffold material alone (group 2), or implanted with a scaffold together with 0.5 million MSCs (group 3) or 5 million MSCs (group 4). The rats were killed 8 weeks after surgery. Histological and histomorphometrical evaluation of the implant as well as micro-CT imaging of the vertebrae were performed.

resultsWe observed a significant effect on the formation of new bone tissue in the defect in group 4 when compared to the other groups and a reduced inflammatory reaction in both groups receiving a scaffold and MSCs. We did not detect any substantial pathological changes or tumor formation after graft implantation.

conclusionsMSCs in combination with a hydroxyapatite scaffold improved the repair of a model bone defect and might represent a safe and effective alternative in the treatment of vertebral bone defects.

Indexed as

DurapatiteTissue ScaffoldsAnimalsBone TransplantationDisease Models, AnimalHumansLumbar VertebraeMaleMesenchymal Stem Cell TransplantationRadiographyRandom AllocationRatsRats, WistarSpinal InjuriesTissue EngineeringWound HealingDurapatite

Identifiers

PMID24013719
PMCPMC3843808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.